bioRxivCancer BiologyPreprint
Invasive cancer and spontaneous regression two weeks after papillomavirus infection
Andrea BilgeriD, Ella T. Ward-ShawiD, Denis L. LeeiD, Renee E. KingiD, Michael A. NewtoniD, Darya G. Buehler, Kristina A. MatkowskyjiD, John P. SundbergiD, Rong HuiD, Paul F. LambertiD
Abstract
Development of invasive cancer in mammals is thought to require months or years after initial events such as mutation or viral infection. Rarely, invasive cancers regress spontaneously. We show that cancers can develop and regress on a timescale of weeks, not months or years. Invasive squamous cell carcinomas developed in normal adult, immune-competent mice as soon as 2 weeks after infection with mouse papillomavirus MmuPV1. Tumor development, regression or persistence was tissue- and strain-dependent. Cancers in infected mice developed rapidly at sites also prone to papillomavirus-induced tumors and cancers in humans - the throat, anus, and skin - and their frequency was increased in mice constitutively expressing the papillomavirus E5 oncogene, which MmuPV1 lacks. Cancers and dysplasia in the throat and anus regressed completely within 4-8 weeks of infection; however, skin lesions in the ear persisted. T-cell depletion in the mouse showed that regression of throat and anal tumors requires T cells. We conclude that papillomavirus infection suffices for rapid onset of invasive cancer, and persistence of lesions depends on factors including tissue type and host immunity. The speed of these events should promote rapid progress in the study of viral cancer development, persistence, and regression. Summary Graphic O_FIG O_LINKSMALLFIG WIDTH=200 HEIGHT=112 SRC="FIGDIR/small/611275v1_ufig1.gif" ALT="Figure 1"> View larger version (33K): org.highwire.dtl.DTLVardef@1da9642org.highwire.dtl.DTLVardef@1bef109org.highwire.dtl.DTLVardef@c2ba0eorg.highwire.dtl.DTLVardef@451baf_HPS_FORMAT_FIGEXP M_FIG C_FIG
- organism: mouse
- research focus: cancer & tumor microenvironment
- research focus: host-pathogen & immune response
- research focus: development & morphogenesis
- research focus: cell type annotation
- approach: experimental assay
- Citations
- 3
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Inhibition of Cellular MEK/ERK Signaling Suppresses Murine Papillomavirus Type 1 Replicative Activities and Promotes Tumor Regression
A. J. Luna, J. M. Young, … M. A. Ozbun·bioRxiv·Mar 14, 2023
- The Mus musculus papillomavirus type 1 E7 protein binds to the retinoblastoma tumor suppressor - implications for viral pathogenesis
Tao Wei, Miranda R. Grace, … Karl Münger·mBioPeer-reviewed·Aug 31, 2021
- A novel lineage-tracing mouse model for MmuPV1 infection enables in vivo studies in the absence of cytopathic effects
- The mouse papillomavirus epigenetic signature is characterised by DNA hypermethylation after lesion regression
A. M. Tschirley, P. A. Stockwell, … M. H. Hibma·bioRxiv·Apr 19, 2021
- Murine cytomegalovirus infection of melanoma lesions delays tumor growth by recruiting and re-polarizing monocytic phagocytes in the tumor
N. A. Wilski, C. Del Casale, … C. M. Snyder·bioRxiv·Apr 6, 2019
- Immune surveillance in clinical regression of pre-invasive squamous cell lung cancer
A. Pennycuick, V. H. Teixeira, … S. M. Janes·bioRxiv·Nov 10, 2019